Teva has agreed to pay $750 million over the next five years to settle litigation with Israel’s tax authorities.
The deal settles all pending disputes …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Through this partnership, the companies intend to innovate new therapeutics and expedite the drug discovery and development process. Credit: Volha_R/Shutterstock. Generate:Biomedicines and Novartis have entered
Hucko is an MD/MPH student. *Patient’s name has been changed As a medical student on my primary care rotation, I reviewed my next patient’s medical
A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were treated in both ears.